{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:48:11Z","timestamp":1775609291865,"version":"3.50.1"},"publisher-location":"Cham","reference-count":107,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030471880","type":"print"},{"value":"9783030471897","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-47189-7_10","type":"book-chapter","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T19:02:44Z","timestamp":1603998164000},"page":"169-183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Androgen Signaling in the Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"Berna C.","family":"\u00d6zdemir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"10_CR1","doi-asserted-by":"crossref","unstructured":"Leach DA, Buchanan G (2017) Stromal androgen receptor in prostate cancer development and progression. Cancers (Basel) 9(1)","DOI":"10.3390\/cancers9010010"},{"issue":"Suppl 1","key":"10_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00280-005-0102-8","volume":"56","author":"S Kato","year":"2005","unstructured":"Kato S et al (2005) Function of nuclear sex hormone receptors in gene regulation. Cancer Chemother Pharmacol 56(Suppl 1):4\u20139","journal-title":"Cancer Chemother Pharmacol"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3389\/fchem.2019.00651","volume":"7","author":"A Zamagni","year":"2019","unstructured":"Zamagni A et al (2019) Non-nuclear AR signaling in prostate cancer. Front Chem 7:651","journal-title":"Front Chem"},{"issue":"4","key":"10_CR4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1210\/en.2018-00987","volume":"160","author":"P Thomas","year":"2019","unstructured":"Thomas P (2019) Membrane androgen receptors unrelated to nuclear steroid receptors. Endocrinology 160(4):772\u2013781","journal-title":"Endocrinology"},{"issue":"6","key":"10_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1432-0436.2008.00290.x","volume":"76","author":"GR Cunha","year":"2008","unstructured":"Cunha GR (2008) Mesenchymal-epithelial interactions: past, present, and future. Differentiation 76(6):578\u2013586","journal-title":"Differentiation"},{"issue":"16","key":"10_CR6","first-page":"6064","volume":"61","author":"Y Wang","year":"2001","unstructured":"Wang Y et al (2001) A human prostatic epithelial model of hormonal carcinogenesis. Cancer Res 61(16):6064\u20136072","journal-title":"Cancer Res"},{"issue":"8","key":"10_CR7","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/emmm.201101140","volume":"4","author":"KP Lai","year":"2012","unstructured":"Lai KP et al (2012) Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines\/chemokines. EMBO Mol Med 4(8):791\u2013807","journal-title":"EMBO Mol Med"},{"issue":"8","key":"10_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/pros.20927","volume":"69","author":"P Wikstrom","year":"2009","unstructured":"Wikstrom P et al (2009) Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients. Prostate 69(8):799\u2013809","journal-title":"Prostate"},{"issue":"12","key":"10_CR9","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1172\/JCI99159","volume":"128","author":"A Clocchiatti","year":"2018","unstructured":"Clocchiatti A et al (2018) Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation. J Clin Invest 128(12):5531\u20135548","journal-title":"J Clin Invest"},{"key":"10_CR10","doi-asserted-by":"crossref","unstructured":"Schweizer MT, Yu EY (2017) AR-signaling in human malignancies: prostate cancer and beyond. Cancers (Basel) 9(1)","DOI":"10.3390\/cancers9010007"},{"issue":"8","key":"10_CR11","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1242\/dev.148270","volume":"144","author":"R Toivanen","year":"2017","unstructured":"Toivanen R, Shen MM (2017) Prostate organogenesis: tissue induction, hormonal regulation and cell type specification. Development 144(8):1382\u20131398","journal-title":"Development"},{"issue":"2","key":"10_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jez.1402050203","volume":"205","author":"GR Cunha","year":"1978","unstructured":"Cunha GR, Lung B (1978) The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. J Exp Zool 205(2):181\u2013193","journal-title":"J Exp Zool"},{"issue":"6","key":"10_CR13","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1210\/endo.132.6.7684975","volume":"132","author":"AA Donjacour","year":"1993","unstructured":"Donjacour AA, Cunha GR (1993) Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice. Endocrinology 132(6):2342\u20132350","journal-title":"Endocrinology"},{"issue":"1","key":"10_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1210\/me.2011-1189","volume":"26","author":"KP Lai","year":"2012","unstructured":"Lai KP et al (2012) Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor. Mol Endocrinol 26(1):52\u201366","journal-title":"Mol Endocrinol"},{"issue":"5","key":"10_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/pros.21264","volume":"71","author":"S Yu","year":"2011","unstructured":"Yu S et al (2011) Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells. Prostate 71(5):517\u2013524","journal-title":"Prostate"},{"issue":"4","key":"10_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/pros.21445","volume":"72","author":"S Yu","year":"2012","unstructured":"Yu S et al (2012) Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts. Prostate 72(4):437\u2013449","journal-title":"Prostate"},{"issue":"3","key":"10_CR17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1210\/endo-97-3-665","volume":"97","author":"GR Cunha","year":"1975","unstructured":"Cunha GR (1975) Age-dependent loss of sensitivity of female urogenital sinus to androgenic conditions as a function of the epithelia-stromal interaction in mice. Endocrinology 97(3):665\u2013673","journal-title":"Endocrinology"},{"issue":"3","key":"10_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1432-0436.1998.6330131.x","volume":"63","author":"SW Hayward","year":"1998","unstructured":"Hayward SW et al (1998) Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation 63(3):131\u2013140","journal-title":"Differentiation"},{"issue":"2","key":"10_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000147794","volume":"155","author":"SW Hayward","year":"1996","unstructured":"Hayward SW et al (1996) Stromal development in the ventral prostate, anterior prostate and seminal vesicle of the rat. Acta Anat (Basel) 155(2):94\u2013103","journal-title":"Acta Anat (Basel)"},{"issue":"2","key":"10_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1210\/endo-114-2-511","volume":"114","author":"SJ Berry","year":"1984","unstructured":"Berry SJ, Isaacs JT (1984) Comparative aspects of prostatic growth and androgen metabolism with aging in the dog versus the rat. Endocrinology 114(2):511\u2013520","journal-title":"Endocrinology"},{"issue":"19","key":"10_CR21","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1001\/jama.296.19.2351","volume":"296","author":"LS Marks","year":"2006","unstructured":"Marks LS et al (2006) Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA 296(19):2351\u20132361","journal-title":"JAMA"},{"issue":"10","key":"10_CR22","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1016\/j.ajpath.2014.06.022","volume":"184","author":"M Singh","year":"2014","unstructured":"Singh M et al (2014) Stromal androgen receptor in prostate development and cancer. Am J Pathol 184(10):2598\u20132607","journal-title":"Am J Pathol"},{"issue":"3","key":"10_CR23","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1210\/endo.140.3.6585","volume":"140","author":"M El-Alfy","year":"1999","unstructured":"El-Alfy M et al (1999) Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry. Endocrinology 140(3):1481\u20131491","journal-title":"Endocrinology"},{"key":"10_CR24","doi-asserted-by":"crossref","unstructured":"Vickman RE, Franco OE, Moline DC, Vander Griend DJ, Thumbikat P, Hayward SW (2019) The role of the androgen receptor in prostate development and benign prostatic hyperplasia: a review. Asian J Urol","DOI":"10.1016\/j.ajur.2019.10.003"},{"issue":"2","key":"10_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/sj.cdd.4400797","volume":"8","author":"T Kurita","year":"2001","unstructured":"Kurita T et al (2001) Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system. Cell Death Differ 8(2):192\u2013200","journal-title":"Cell Death Differ"},{"issue":"9\u201310","key":"10_CR26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1046\/j.1432-0436.2002.700902.x","volume":"70","author":"GR Cunha","year":"2002","unstructured":"Cunha GR, Hayward SW, Wang YZ (2002) Role of stroma in carcinogenesis of the prostate. Differentiation 70(9\u201310):473\u2013485","journal-title":"Differentiation"},{"issue":"1","key":"10_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.eururo.2013.08.015","volume":"65","author":"M Khera","year":"2014","unstructured":"Khera M et al (2014) A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 65(1):115\u2013123","journal-title":"Eur Urol"},{"issue":"6B","key":"10_CR28","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1111\/j.1582-4934.2008.00279.x","volume":"12","author":"Y Li","year":"2008","unstructured":"Li Y et al (2008) Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion. J Cell Mol Med 12(6B):2790\u20132798","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10_CR29","first-page":"423","volume":"61","author":"SM Henshall","year":"2001","unstructured":"Henshall SM et al (2001) Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. Cancer Res 61(2):423\u2013427","journal-title":"Cancer Res"},{"issue":"34","key":"10_CR30","doi-asserted-by":"publisher","first-page":"12182","DOI":"10.1073\/pnas.0804700105","volume":"105","author":"Y Niu","year":"2008","unstructured":"Niu Y et al (2008) Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci U S A 105(34):12182\u201312187","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"34","key":"10_CR31","doi-asserted-by":"publisher","first-page":"12188","DOI":"10.1073\/pnas.0804701105","volume":"105","author":"Y Niu","year":"2008","unstructured":"Niu Y et al (2008) Targeting the stromal androgen receptor in primary prostate tumors at earlier stages. Proc Natl Acad Sci U S A 105(34):12188\u201312193","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10_CR32","doi-asserted-by":"publisher","first-page":"16135","DOI":"10.18632\/oncotarget.3873","volume":"6","author":"DA Leach","year":"2015","unstructured":"Leach DA et al (2015) Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome. Oncotarget 6(18):16135\u201316150","journal-title":"Oncotarget"},{"issue":"8","key":"10_CR33","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/1878-0261.12327","volume":"12","author":"B Cioni","year":"2018","unstructured":"Cioni B et al (2018) Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration. Mol Oncol 12(8):1308\u20131323","journal-title":"Mol Oncol"},{"key":"10_CR34","doi-asserted-by":"crossref","unstructured":"Henke A et al (2016) Reduced contractility and motility of prostatic cancer-associated fibroblasts after inhibition of heat shock protein 90. Cancers (Basel) 8(9)","DOI":"10.3390\/cancers8090077"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.mce.2016.09.010","volume":"439","author":"DA Leach","year":"2017","unstructured":"Leach DA et al (2017) Cell-lineage specificity and role of AP-1 in the prostate fibroblast androgen receptor cistrome. Mol Cell Endocrinol 439:261\u2013272","journal-title":"Mol Cell Endocrinol"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2017.05.006","volume":"471","author":"C Nash","year":"2018","unstructured":"Nash C et al (2018) Genome-wide analysis of AR binding and comparison with transcript expression in primary human fetal prostate fibroblasts and cancer associated fibroblasts. Mol Cell Endocrinol 471:1\u201314","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10_CR37","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1083\/jcb.200211099","volume":"161","author":"G Castoria","year":"2003","unstructured":"Castoria G et al (2003) Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J Cell Biol 161(3):547\u2013556","journal-title":"J Cell Biol"},{"issue":"2","key":"10_CR38","doi-asserted-by":"publisher","first-page":"e17218","DOI":"10.1371\/journal.pone.0017218","volume":"6","author":"G Castoria","year":"2011","unstructured":"Castoria G et al (2011) Androgen-induced cell migration: role of androgen receptor\/filamin A association. PLoS One 6(2):e17218","journal-title":"PLoS One"},{"key":"10_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.497","volume":"5","author":"G Castoria","year":"2014","unstructured":"Castoria G et al (2014) Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells. Cell Death Dis 5:e1548","journal-title":"Cell Death Dis"},{"issue":"3","key":"10_CR40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s12032-013-0674-9","volume":"30","author":"S Yu","year":"2013","unstructured":"Yu S et al (2013) Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion. Med Oncol 30(3):674","journal-title":"Med Oncol"},{"issue":"1","key":"10_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016027","volume":"6","author":"MJ Tanner","year":"2011","unstructured":"Tanner MJ et al (2011) Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells. PLoS One 6(1):e16027","journal-title":"PLoS One"},{"issue":"3","key":"10_CR42","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1530\/JOE-14-0611","volume":"224","author":"V Torres-Estay","year":"2015","unstructured":"Torres-Estay V et al (2015) Androgen receptor in human endothelial cells. J Endocrinol 224(3):R131\u2013R137","journal-title":"J Endocrinol"},{"issue":"4","key":"10_CR43","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/en.2003-0789","volume":"145","author":"AK Death","year":"2004","unstructured":"Death AK et al (2004) Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway. Endocrinology 145(4):1889\u20131897","journal-title":"Endocrinology"},{"issue":"6","key":"10_CR44","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1073\/pnas.052703199","volume":"99","author":"TK Mukherjee","year":"2002","unstructured":"Mukherjee TK et al (2002) Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. Proc Natl Acad Sci U S A 99(6):4055\u20134060","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10_CR45","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1161\/CIRCULATIONAHA.113.001533","volume":"128","author":"S Yoshida","year":"2013","unstructured":"Yoshida S et al (2013) Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling. Circulation 128(1):60\u201371","journal-title":"Circulation"},{"issue":"5","key":"10_CR46","doi-asserted-by":"publisher","first-page":"e0154987","DOI":"10.1371\/journal.pone.0154987","volume":"11","author":"J Wu","year":"2016","unstructured":"Wu J et al (2016) Influence of androgen receptor in vascular cells on reperfusion following hindlimb ischaemia. PLoS One 11(5):e0154987","journal-title":"PLoS One"},{"issue":"2","key":"10_CR47","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.20091924","volume":"207","author":"DP Sieveking","year":"2010","unstructured":"Sieveking DP et al (2010) A sex-specific role for androgens in angiogenesis. J Exp Med 207(2):345\u2013352","journal-title":"J Exp Med"},{"issue":"12 Pt 1","key":"10_CR48","first-page":"2507","volume":"3","author":"IB Joseph","year":"1997","unstructured":"Joseph IB et al (1997) Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Clin Cancer Res 3(12 Pt 1):2507\u20132511","journal-title":"Clin Cancer Res"},{"key":"10_CR49","doi-asserted-by":"publisher","first-page":"37085","DOI":"10.1038\/srep37085","volume":"6","author":"Z Guan","year":"2016","unstructured":"Guan Z et al (2016) Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT --> NF-kappaB --> CXCL5 signaling. Sci Rep 6:37085","journal-title":"Sci Rep"},{"key":"10_CR50","doi-asserted-by":"crossref","unstructured":"Eisermann K, Fraizer G (2017) The androgen receptor and VEGF: mechanisms of androgen-regulated angiogenesis in prostate cancer. Cancers (Basel) 9(4)","DOI":"10.3390\/cancers9040032"},{"issue":"10","key":"10_CR51","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL (2016) Sex differences in immune responses. Nat Rev Immunol 16(10):626\u2013638","journal-title":"Nat Rev Immunol"},{"key":"10_CR52","doi-asserted-by":"crossref","unstructured":"Ozdemir BC, Dotto GP (2019) Sex hormones and anticancer immunity. Clin Cancer Res","DOI":"10.1158\/1078-0432.CCR-19-0137"},{"issue":"3","key":"10_CR53","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/1096-9896(0000)9999:9999<::AID-PATH803>3.0.CO;2-W","volume":"193","author":"A Mantalaris","year":"2001","unstructured":"Mantalaris A et al (2001) Localization of androgen receptor expression in human bone marrow. J Pathol 193(3):361\u2013366","journal-title":"J Pathol"},{"issue":"5","key":"10_CR54","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.ajpath.2012.07.008","volume":"181","author":"JJ Lai","year":"2012","unstructured":"Lai JJ et al (2012) Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice. Am J Pathol 181(5):1504\u20131512","journal-title":"Am J Pathol"},{"issue":"5","key":"10_CR55","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.4049\/jimmunol.1102683","volume":"188","author":"J Yan","year":"2012","unstructured":"Yan J et al (2012) Glutathione reductase facilitates host defense by sustaining phagocytic oxidative burst and promoting the development of neutrophil extracellular traps. J Immunol 188(5):2316\u20132327","journal-title":"J Immunol"},{"issue":"6","key":"10_CR56","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106(6):dju124","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"10_CR57","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles AJ et al (2015) The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 21(8):938\u2013945","journal-title":"Nat Med"},{"issue":"5","key":"10_CR58","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1084\/jem.20082521","volume":"206","author":"KH Chuang","year":"2009","unstructured":"Chuang KH et al (2009) Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor. J Exp Med 206(5):1181\u20131199","journal-title":"J Exp Med"},{"issue":"5","key":"10_CR59","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/cbf.1669","volume":"28","author":"DP Marin","year":"2010","unstructured":"Marin DP et al (2010) Testosterone suppresses oxidative stress in human neutrophils. Cell Biochem Funct 28(5):394\u2013402","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"10_CR60","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbrc.2013.10.042","volume":"441","author":"M Aomatsu","year":"2013","unstructured":"Aomatsu M et al (2013) Gender difference in tumor necrosis factor-alpha production in human neutrophils stimulated by lipopolysaccharide and interferon-gamma. Biochem Biophys Res Commun 441(1):220\u2013225","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","volume":"5","author":"DI Gabrilovich","year":"2017","unstructured":"Gabrilovich DI (2017) Myeloid-derived suppressor cells. Cancer Immunol Res 5(1):3\u20138","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"10_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156549","volume":"11","author":"S Zhang","year":"2016","unstructured":"Zhang S et al (2016) Finasteride enhances the generation of human myeloid-derived suppressor cells by up-regulating the COX2\/PGE2 pathway. PLoS One 11(6):e0156549","journal-title":"PLoS One"},{"issue":"7714","key":"10_CR63","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41586-018-0266-0","volume":"559","author":"A Calcinotto","year":"2018","unstructured":"Calcinotto A et al (2018) IL-23 secreted by myeloid cells drives castration-resistant prostate cancer. Nature 559(7714):363\u2013369","journal-title":"Nature"},{"issue":"8","key":"10_CR64","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.it.2014.06.006","volume":"35","author":"SJ Jenkins","year":"2014","unstructured":"Jenkins SJ, Hume DA (2014) Homeostasis in the mononuclear phagocyte system. Trends Immunol 35(8):358\u2013367","journal-title":"Trends Immunol"},{"key":"10_CR65","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","volume":"5","author":"N Wang","year":"2014","unstructured":"Wang N, Liang H, Zen K (2014) Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front Immunol 5:614","journal-title":"Front Immunol"},{"issue":"3","key":"10_CR66","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/BF00916817","volume":"9","author":"DJ Tollerud","year":"1989","unstructured":"Tollerud DJ et al (1989) The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers. J Clin Immunol 9(3):214\u2013222","journal-title":"J Clin Immunol"},{"issue":"3","key":"10_CR67","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/01.CIR.101.3.224","volume":"101","author":"JA McCrohon","year":"2000","unstructured":"McCrohon JA et al (2000) Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherogenesis. Circulation 101(3):224\u2013226","journal-title":"Circulation"},{"issue":"10","key":"10_CR68","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.4049\/jimmunol.1800352","volume":"201","author":"M Becerra-Diaz","year":"2018","unstructured":"Becerra-Diaz M et al (2018) Androgen and androgen receptor as enhancers of M2 macrophage polarization in allergic lung inflammation. J Immunol 201(10):2923\u20132933","journal-title":"J Immunol"},{"issue":"5","key":"10_CR69","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1172\/JCI0215704","volume":"110","author":"GS Ashcroft","year":"2002","unstructured":"Ashcroft GS, Mills SJ (2002) Androgen receptor-mediated inhibition of cutaneous wound healing. J Clin Invest 110(5):615\u2013624","journal-title":"J Clin Invest"},{"issue":"12","key":"10_CR70","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1172\/JCI39335","volume":"119","author":"JJ Lai","year":"2009","unstructured":"Lai JJ et al (2009) Monocyte\/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression. J Clin Invest 119(12):3739\u20133751","journal-title":"J Clin Invest"},{"issue":"22","key":"10_CR71","doi-asserted-by":"publisher","first-page":"18376","DOI":"10.1074\/jbc.M112.355164","volume":"287","author":"X Wang","year":"2012","unstructured":"Wang X et al (2012) Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation. J Biol Chem 287(22):18376\u201318385","journal-title":"J Biol Chem"},{"issue":"45","key":"10_CR72","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1038\/onc.2008.267","volume":"27","author":"I Waldhauer","year":"2008","unstructured":"Waldhauer I, Steinle A (2008) NK cells and cancer immunosurveillance. Oncogene 27(45):5932\u20135943","journal-title":"Oncogene"},{"issue":"2","key":"10_CR73","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cellimm.2011.10.009","volume":"272","author":"M Abdullah","year":"2012","unstructured":"Abdullah M et al (2012) Gender effect on in vitro lymphocyte subset levels of healthy individuals. Cell Immunol 272(2):214\u2013219","journal-title":"Cell Immunol"},{"issue":"2","key":"10_CR74","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/pros.2990210204","volume":"21","author":"M Kastelan","year":"1992","unstructured":"Kastelan M, Kraljic I, Tarle M (1992) NK cell activity in treated prostate cancer patients as a probe for circulating tumor cells: hormone regulatory effects in vivo. Prostate 21(2):111\u2013120","journal-title":"Prostate"},{"key":"10_CR75","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.canlet.2017.03.035","volume":"398","author":"SJ Lin","year":"2017","unstructured":"Lin SJ et al (2017) Natural killer cells suppress enzalutamide resistance and cell invasion in the castration resistant prostate cancer via targeting the androgen receptor splicing variant 7 (ARv7). Cancer Lett 398:62\u201369","journal-title":"Cancer Lett"},{"issue":"4","key":"10_CR76","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1158\/1535-7163.MCT-15-0706","volume":"15","author":"L Shi","year":"2016","unstructured":"Shi L et al (2016) Targeting androgen receptor (AR)-->IL12A signal enhances efficacy of sorafenib plus NK cells immunotherapy to better suppress HCC progression. Mol Cancer Ther 15(4):731\u2013742","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"10_CR77","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/cr.2014.92","volume":"24","author":"C Dong","year":"2014","unstructured":"Dong C (2014) Targeting Th17 cells in immune diseases. Cell Res 24(8):901\u2013903","journal-title":"Cell Res"},{"issue":"3","key":"10_CR78","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/imm.13064","volume":"157","author":"J Stockis","year":"2019","unstructured":"Stockis J, Roychoudhuri R, Halim TYF (2019) Regulation of regulatory T cells in cancer. Immunology 157(3):219\u2013231","journal-title":"Immunology"},{"issue":"4","key":"10_CR79","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/humupd\/dmi008","volume":"11","author":"A Bouman","year":"2005","unstructured":"Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11(4):411\u2013423","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10_CR80","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0303-7207(95)03479-Q","volume":"109","author":"SM Viselli","year":"1995","unstructured":"Viselli SM et al (1995) Immunochemical and flow cytometric analysis of androgen receptor expression in thymocytes. Mol Cell Endocrinol 109(1):19\u201326","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"10_CR81","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0039-128X(02)00013-2","volume":"67","author":"WP Benten","year":"2002","unstructured":"Benten WP, Stephan C, Wunderlich F (2002) B cells express intracellular but not surface receptors for testosterone and estradiol. Steroids 67(7):647\u2013654","journal-title":"Steroids"},{"issue":"1","key":"10_CR82","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1096\/fasebj.13.1.123","volume":"13","author":"WP Benten","year":"1999","unstructured":"Benten WP et al (1999) Functional testosterone receptors in plasma membranes of T cells. FASEB J 13(1):123\u2013133","journal-title":"FASEB J"},{"issue":"2\u20133","key":"10_CR83","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1385\/IR:23:2-3:281","volume":"23","author":"NJ Olsen","year":"2001","unstructured":"Olsen NJ, Kovacs WJ (2001) Effects of androgens on T and B lymphocyte development. Immunol Res 23(2\u20133):281\u2013288","journal-title":"Immunol Res"},{"issue":"27","key":"10_CR84","doi-asserted-by":"publisher","first-page":"9887","DOI":"10.1073\/pnas.1402468111","volume":"111","author":"HT Kissick","year":"2014","unstructured":"Kissick HT et al (2014) Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation. Proc Natl Acad Sci U S A 111(27):9887\u20139892","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10_CR85","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1677\/joe.0.1690299","volume":"169","author":"KA Messingham","year":"2001","unstructured":"Messingham KA et al (2001) Testosterone receptor blockade restores cellular immunity in male mice after burn injury. J Endocrinol 169(2):299\u2013308","journal-title":"J Endocrinol"},{"issue":"6","key":"10_CR86","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1158\/0008-5472.CAN-11-2602","volume":"72","author":"L Lessard","year":"2012","unstructured":"Lessard L et al (2012) PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer. Cancer Res 72(6):1529\u20131537","journal-title":"Cancer Res"},{"issue":"10","key":"10_CR87","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.4049\/jimmunol.173.10.6098","volume":"173","author":"AC Roden","year":"2004","unstructured":"Roden AC et al (2004) Augmentation of T cell levels and responses induced by androgen deprivation. J Immunol 173(10):6098\u20136108","journal-title":"J Immunol"},{"issue":"5","key":"10_CR88","doi-asserted-by":"publisher","first-page":"E856","DOI":"10.1152\/ajpendo.00484.2005","volume":"290","author":"ST Page","year":"2006","unstructured":"Page ST et al (2006) Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and\/or its metabolites. Am J Physiol Endocrinol Metab 290(5):E856\u2013E863","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10_CR89","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4049\/jimmunol.162.1.35","volume":"162","author":"BF Bebo Jr","year":"1999","unstructured":"Bebo BF Jr et al (1999) Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol 162(1):35\u201340","journal-title":"J Immunol"},{"issue":"4","key":"10_CR90","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.4049\/jimmunol.167.4.2060","volume":"167","author":"SM Liva","year":"2001","unstructured":"Liva SM, Voskuhl RR (2001) Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol 167(4):2060\u20132067","journal-title":"J Immunol"},{"issue":"4","key":"10_CR91","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1600-0897.2004.00216.x","volume":"52","author":"E Posma","year":"2004","unstructured":"Posma E et al (2004) The effect of testosterone on cytokine production in the specific and non-specific immune response. Am J Reprod Immunol 52(4):237\u2013243","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"10_CR92","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3109\/13685538.2010.502268","volume":"14","author":"A Tsujimura","year":"2011","unstructured":"Tsujimura A et al (2011) Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism. Aging Male 14(1):76\u201381","journal-title":"Aging Male"},{"key":"10_CR93","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3389\/fimmu.2015.00493","volume":"6","author":"J Nie","year":"2015","unstructured":"Nie J et al (2015) FOXP3(+) treg cells and gender bias in autoimmune diseases. Front Immunol 6:493","journal-title":"Front Immunol"},{"issue":"15","key":"10_CR94","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1091\/mbc.E14-08-1323","volume":"26","author":"M Walecki","year":"2015","unstructured":"Walecki M et al (2015) Androgen receptor modulates Foxp3 expression in CD4+CD25+Foxp3+ regulatory T-cells. Mol Biol Cell 26(15):2845\u20132857","journal-title":"Mol Biol Cell"},{"issue":"5","key":"10_CR95","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc.2016.30","volume":"16","author":"A Clocchiatti","year":"2016","unstructured":"Clocchiatti A et al (2016) Sexual dimorphism in cancer. Nat Rev Cancer 16(5):330\u2013339","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 2","key":"10_CR96","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1038\/bmt.2015.101","volume":"50","author":"E Velardi","year":"2015","unstructured":"Velardi E, Dudakov JA, van den Brink MR (2015) Sex steroid ablation: an immunoregenerative strategy for immunocompromised patients. Bone Marrow Transplant 50(Suppl 2):S77\u2013S81","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10_CR97","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1073\/pnas.1321060111","volume":"111","author":"D Furman","year":"2014","unstructured":"Furman D et al (2014) Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A 111(2):869\u2013874","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4049\/jimmunol.161.1.27","volume":"161","author":"G Smithson","year":"1998","unstructured":"Smithson G et al (1998) The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. J Immunol 161(1):27\u201334","journal-title":"J Immunol"},{"issue":"4","key":"10_CR99","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1210\/me.2008-0106","volume":"23","author":"S Altuwaijri","year":"2009","unstructured":"Altuwaijri S et al (2009) Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells. Mol Endocrinol 23(4):444\u2013453","journal-title":"Mol Endocrinol"},{"issue":"12","key":"10_CR100","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","volume":"37","author":"A Gardner","year":"2016","unstructured":"Gardner A, Ruffell B (2016) Dendritic cells and cancer immunity. Trends Immunol 37(12):855\u2013865","journal-title":"Trends Immunol"},{"issue":"5","key":"10_CR101","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00262-017-1972-4","volume":"66","author":"MG Thompson","year":"2017","unstructured":"Thompson MG et al (2017) FOXO3, estrogen receptor alpha, and androgen receptor impact tumor growth rate and infiltration of dendritic cell subsets differentially between male and female mice. Cancer Immunol Immunother 66(5):615\u2013625","journal-title":"Cancer Immunol Immunother"},{"issue":"6123","key":"10_CR102","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.1233521","volume":"339","author":"JG Markle","year":"2013","unstructured":"Markle JG et al (2013) Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339(6123):1084\u20131088","journal-title":"Science"},{"issue":"2","key":"10_CR103","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.immuni.2013.08.013","volume":"39","author":"L Yurkovetskiy","year":"2013","unstructured":"Yurkovetskiy L et al (2013) Gender bias in autoimmunity is influenced by microbiota. Immunity 39(2):400\u2013412","journal-title":"Immunity"},{"key":"10_CR104","unstructured":"Routy, B., et al., Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science, 2018 359(6371):91-97."},{"issue":"6230","key":"10_CR105","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.aaa4972","volume":"348","author":"WS Garrett","year":"2015","unstructured":"Garrett WS (2015) Cancer and the microbiota. Science 348(6230):80\u201386","journal-title":"Science"},{"issue":"6","key":"10_CR106","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1200\/JCO.2002.20.6.1491","volume":"20","author":"JA Sloan","year":"2002","unstructured":"Sloan JA et al (2002) Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol 20(6):1491\u20131498","journal-title":"J Clin Oncol"},{"issue":"4","key":"10_CR107","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1200\/JCO.2005.03.171","volume":"23","author":"S Singh","year":"2005","unstructured":"Singh S et al (2005) Influence of sex on toxicity and treatment outcome in small-cell lung cancer. J Clin Oncol 23(4):850\u2013856","journal-title":"J Clin Oncol"}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-47189-7_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T22:09:46Z","timestamp":1674770986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-47189-7_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"ISBN":["9783030471880","9783030471897"],"references-count":107,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-47189-7_10","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"30 October 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}